Evaluation of the Impact of Advanced Glycation End-Products on Peripheral Neuropathy Outcomes in Type 2 Diabetes
Indumathi Singh, Tushar Issar, Ann M. Poynten, Kerry-Lee Milner, Arun V. Krishnan, Roshan Dhanapalaratnam · 2024
Read Evaluation of the Impact of Advanced Glycation End-Products on Peripheral Neuropathy Outcomes in Type 2 Diabetes by Indumathi Singh, Tushar Issar, Ann M. Poynten, Kerry-Lee Milner, Arun V. Krishnan, Roshan Dhanapalaratnam (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11592312.txt.
Description
Indumathi Singh and colleagues studied whether sugar-damaged proteins build up more in people with worse diabetic nerve damage. Their paper, published in twenty twenty-four, recruited people with type two diabetes and measured these compounds through the skin with a light-based device. Participants also had clinical exams for nerve damage, nerve ultrasound, electrical nerve tests, and tests of how nerve fibers respond to stimulation. The team then checked how the compound levels lined up with each nerve measure.
At first glance, higher levels tracked weakly with worse neuropathy scores and slower nerve signals. Once age and other confounding factors were taken into account, those links were no longer clear. The authors conclude that buildup of these compounds, as measured in skin, does not by itself explain differences in nerve damage among people with type two diabetes.
Catalog record
| CREATOR | Indumathi Singh, Tushar Issar, Ann M. Poynten, Kerry-Lee Milner, Arun V. Krishnan, Roshan Dhanapalaratnam |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |